Corporate Transactions: Healthcare and Life Sciences
- Defending health insurers in a wide variety of class actions and significant multi-district and other multi-jurisdictional litigation, where we have either defeated the class or won on summary judgment.
- Representing corporations and individuals in investigations and criminal, regulatory and civil proceedings by governmental authorities and qui tam plaintiffs.
- Advising with respect to antitrust issues resulting from our unique combination of public and private enforcement experience, including a broad range of transactional, counseling and litigation matters, and virtually every conceivable antitrust issue involving stakeholders throughout the healthcare system.
- Defending healthcare companies, and their officers and directors, in shareholder class and derivative litigation in courts around the country.
- Managing and litigating a wide array of ERISA matters, including private class actions, investigations and enforcement actions commenced by the U.S. Department of Labor and the Pension Benefit Guaranty Corporation, and other administrative agencies.
Life Sciences Litigation
Corporate Department Chairman Michael Aiello and head of Antitrust/Competition named “Trailblazers” in M&A and Antitrust, respectively for notable representations on behalf of clients such as Sanofi, Omnicare and Health Management Associates
National Law Journal 2015
Seven Partners Named Life Science Stars
LMG Life Sciences Guide 2017
Weil Named a “Leading” Firm for Healthcare: Life Sciences
Legal 500 US 2020